736 Intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa is safe, improves quality of life and reduces itch: International Investigative Dermatology (IID) 2018 Meeting Abstract SupplementInternational Investigative Dermatology (IID) 2018

E. Rashidghamat; T. Kadiyirire; J.E. Mellerio; J. McGrath

doi:10.1016/j.jid.2018.03.746

736 Intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa is safe, improves quality of life and reduces itch: International Investigative Dermatology (IID) 2018 Meeting Abstract SupplementInternational Investigative Dermatology (IID) 2018

E. Rashidghamat, T. Kadiyirire, J.E. Mellerio, J. McGrath

Dermatology

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S125
Journal	Journal of Investigative Dermatology
Volume	138
Issue number	5, Supplement
Early online date	19 Apr 2018
DOIs	https://doi.org/10.1016/j.jid.2018.03.746
Publication status	Published - May 2018

Access to Document

10.1016/j.jid.2018.03.746

Cite this

Rashidghamat, E., Kadiyirire, T., Mellerio, J. E., & McGrath, J. (2018). 736 Intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa is safe, improves quality of life and reduces itch: International Investigative Dermatology (IID) 2018 Meeting Abstract SupplementInternational Investigative Dermatology (IID) 2018. Journal of Investigative Dermatology, 138(5, Supplement), S125. https://doi.org/10.1016/j.jid.2018.03.746

Rashidghamat, E. ; Kadiyirire, T. ; Mellerio, J.E. et al. / 736 Intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa is safe, improves quality of life and reduces itch : International Investigative Dermatology (IID) 2018 Meeting Abstract SupplementInternational Investigative Dermatology (IID) 2018. In: Journal of Investigative Dermatology. 2018 ; Vol. 138, No. 5, Supplement. pp. S125.

@article{0047650cf0a8406f986098fc74a97692,

title = "736 Intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa is safe, improves quality of life and reduces itch: International Investigative Dermatology (IID) 2018 Meeting Abstract SupplementInternational Investigative Dermatology (IID) 2018",

author = "E. Rashidghamat and T. Kadiyirire and J.E. Mellerio and J. McGrath",

year = "2018",

month = may,

doi = "10.1016/j.jid.2018.03.746",

language = "English",

volume = "138",

pages = "S125",

journal = "Journal of Investigative Dermatology",

issn = "0022-202X",

publisher = "Nature Publishing Group",

number = "5, Supplement",

}

Rashidghamat, E, Kadiyirire, T, Mellerio, JE & McGrath, J 2018, '736 Intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa is safe, improves quality of life and reduces itch: International Investigative Dermatology (IID) 2018 Meeting Abstract SupplementInternational Investigative Dermatology (IID) 2018', Journal of Investigative Dermatology, vol. 138, no. 5, Supplement, pp. S125. https://doi.org/10.1016/j.jid.2018.03.746

736 Intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa is safe, improves quality of life and reduces itch: International Investigative Dermatology (IID) 2018 Meeting Abstract SupplementInternational Investigative Dermatology (IID) 2018. / Rashidghamat, E.; Kadiyirire, T.; Mellerio, J.E. et al.
In: Journal of Investigative Dermatology, Vol. 138, No. 5, Supplement, 05.2018, p. S125.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - 736 Intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa is safe, improves quality of life and reduces itch

T2 - International Investigative Dermatology (IID) 2018 Meeting Abstract SupplementInternational Investigative Dermatology (IID) 2018

AU - Rashidghamat, E.

AU - Kadiyirire, T.

AU - Mellerio, J.E.

AU - McGrath, J.

PY - 2018/5

Y1 - 2018/5

U2 - 10.1016/j.jid.2018.03.746

DO - 10.1016/j.jid.2018.03.746

M3 - Meeting Abstract

SN - 0022-202X

VL - 138

SP - S125

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

IS - 5, Supplement

ER -

Rashidghamat E, Kadiyirire T, Mellerio JE, McGrath J. 736 Intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa is safe, improves quality of life and reduces itch: International Investigative Dermatology (IID) 2018 Meeting Abstract SupplementInternational Investigative Dermatology (IID) 2018. Journal of Investigative Dermatology. 2018 May;138(5, Supplement):S125. Epub 2018 Apr 19. doi: 10.1016/j.jid.2018.03.746